Connie Lai Hang

Executive

CA·SEDI

Nirvana Life Sciences Inc. (formerly Endocan Solutions Inc.)

Cumul. flow

Total declarations

Company

▲ Purchases (0 ops.)

—

▼ Sales (3 ops.)

€10k

Latest filing published 08 Jun 2022 for Nirvana Life Sciences Inc. (formerly Endocan Solutions Inc.), €2,182.

Filing timeline

BuySale

Connie Lai Hang

Insider track record

Disclosed buys

Disclosed sells

Signal history

Connie Lai Hang: trading record in brief

Connie Lai Hang discloses dealings in Nirvana Life Sciences Inc. (formerly Endocan Solutions Inc.) to SEDI. Over a trading history stretching from 8 April 2022 to 3 June 2022, the count stands at 3 filings.

Sales make up the whole of the open-market record (3 sales, €10k).

The newest entry dates from 8 June 2022: an open-market sale of €2,182, in Nirvana Life Sciences Inc. (formerly Endocan Solutions Inc.). Filings reach the SEDI feed a median of 5 days after the trade. This delay matters because a trade only becomes useful information once it is public. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Source: insider filings from SEDI. Past trades are no guide to future returns.